Evaluation of HIV/AIDS clinical care quality: the case of a referral hospital in North West Ethiopia.
OBJECTIVE
To assess the quality of clinical care provided to patients with HIV in Felege Hiwot Referral Hospital. APPROACH AND DESIGN: Normative evaluation based on Donabedian's structure-process-outcome model of health care quality. Cross-sectional


METHODS
was employed to gather data in September 2007.


METHODS
Felege Hiwot Referral Hospital is a government hospital in North West Ethiopia. The hospital is providing clinical care for patients infected with HIV free of patient charge since 2005.


METHODS
The evaluation used 10 process and 5 outcome indicators of quality measured by reviewing 351 randomly selected patient records and interview with 368 patients. Resource inventory was conducted to assess the availability of trained staff, laboratory facilities and drugs required for provision of HIV care.


RESULTS
All resources recommended by the national antiretroviral therapy (ART) Implementation Guideline including trained staff, laboratory facilities and drugs were continuously available, except for a shortage of cotrimoxazole. Despite this, important components of care and treatment recommended by national treatment guidelines were not delivered for significant portion of patients. The study showed that only 45.9% of patients eligible for cotrimoxazole prophylactic therapy (CPT) and 76.8% of patients eligible for ART were actually taking CPT and ART, respectively. Compliance with national guidelines to monitor patients was also found to be a major problem.


CONCLUSIONS
Availability of resources alone does not ensure the quality of HIV care and treatment. The study results indicate a need for regular monitoring and improvement of processes and outcomes of care in the Ethiopian Health System.
Alemayehu
Yibeltal Kiflie
YK
Jimma University, Ethiopia. kibeltal@gmail.com
Bushen
Oluma Yoseph
OY
Muluneh
Ayalew Tegegn
AT
D000293:Adolescent; D019380:Anti-HIV Agents / Q000600:supply & distribution / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis / Q000592:standards; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D005002:Ethiopia; D005260:Female; D019983:Guideline Adherence / Q000706:statistics & numerical data; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D007223:Infant; D008297:Male; D010043:Outcome and Process Assessment, Health Care / Q000379:methods*; D017060:Patient Satisfaction; D011787:Quality of Health Care; D018119:Stavudine / Q000600:supply & distribution / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000600:supply & distribution / Q000627:therapeutic use; D055815:Young Adult; D015215:Zidovudine / Q000600:supply & distribution / Q000627:therapeutic use
D019380:Anti-HIV Agents; D015215:Zidovudine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D018119:Stavudine
AIDS. 2002 May 3;16(7):1051-8
11953472
JAMA. 2001 Nov 28;286(20):2560-7
11722270
BMJ. 2007 Nov 24;335(7629):1085
17967826
J Acquir Immune Defic Syndr. 2002 May 1;30(1):105-10
12048370
J Antimicrob Chemother. 2004 Jul;54(1):10-3
15163656
AIDS Res Ther. 2006 Mar 20;3:6
16549012
AIDS. 2001 Jun 15;15(9):1181-3
11416722
JAMA. 2000 Oct 4;284(13):1670-6
11015797
AIDS. 1999 Sep 10;13(13):1687-95
10509570
Ethiop Med J. 2006 Jul;44(3):237-44
17447389
N Engl J Med. 2003 Jun 26;348(26):2635-45
12826639
JAMA. 2001 Nov 28;286(20):2568-77
11722271
Milbank Q. 2005;83(4):691-729
16279964
Clin Infect Dis. 2007 May 15;44(10):1361-7
17443476
AIDS. 2005 Jan 28;19(2):163-8
15668541
AIDS Care. 2005 Jan;17(1):10-22
15832830
Lancet. 1999 May 1;353(9163):1463-8
10232311
AIDS. 2000 Sep 8;14(13):1985-91
10997404
Ann Intern Med. 2000 Jul 4;133(1):21-30
10877736
JAMA. 2000 Apr 5;283(13):1715-22
10755498
Milbank Q. 2005;83(4):843-95
16279970
Ann Intern Med. 2003 Apr 15;138(8):620-6
12693883